Expected earnings - Cardiol Therapeutics Inc.
Source: US Earnings Reports
Cardiol Therapeutics Inc. (CRDL) is expected to report $-0.09 for Q3 2025
Cardiol Therapeutics Inc.
NASDAQ: CRDL
CRDL Trading
-3.77% G/L:
$1.02 Last:
122,918 Volume:
$1.06 Open:
CRDL Latest News
February 25, 2026 07:27:00 am
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference
February 10, 2026 07:27:00 am
Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure
January 23, 2026 09:16:00 am
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
January 16, 2026 08:46:00 am
Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
CRDL Stock Data
$107,438,511
95,997,742
4.44%
20
N/A
Pharmaceuticals
Healthcare
CA
Oakville
